Patient-reported outcomes and physician's satisfaction after 28 weeks of treatment with tildrakizumab in moderate-to-severe plaque psoriasis: interim analysis of the noninterventional study TILOT-MedSci.cn - 梅斯（MedSci）

Patient-reported outcomes and physician's satisfaction after 28 weeks of treatment with tildrakizumab in moderate-to-severe plaque psoriasis: interim analysis of the noninterventional study TILOT

Tsianakas, A; Ostendorf, R; Diemert, S; Hinz, T; Pierchalla, P

BRITISH JOURNAL OF DERMATOLOGY, 2022; 186 (1): E40

科室
- - 订阅+
  - 更多科室
工具
服务